Abercrombie & Fitch Co. <ANF.N>: Barclays raises target price to $114 from $78
ANF•Related News
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall
GANX•
Astrana Health, Inc. <ASTH.O>: Truist Securities raises target price to $55 from $47
ASTH•
Everforth ECS wins $30 million DHA health IT modernization contract
EFOR•
Tango Therapeutics Q2 net loss widens as expenses rise
TNGX•
Alamar Biosciences Inc <ALMR.O>: Stifel raises target price to $32 from $28
ALMR•